Analysis and Improvement of Input Errors in Electronic Application Form of Blood Concentration Monitoring of Phenobarbital and Phenytoin Sodium

ZHANG Qingxia; CHU Yanqi; ZENG Yan; SHEN Jianghua; WANG Xin; WANG Yuqin; YAN Suying

doi:10.14009/j.issn.1672-2124.2020.05.028

您当前的位置：

首页 >

文章列表页 >

Analysis and Improvement of Input Errors in Electronic Application Form of Blood Concentration Monitoring of Phenobarbital and Phenytoin Sodium

更新时间：2022-10-08

- Analysis and Improvement of Input Errors in Electronic Application Form of Blood Concentration Monitoring of Phenobarbital and Phenytoin Sodium
- Vol. 20, Issue 5, Pages: 617-619(2020)
- 作者机构：
  
  首都医科大学宣武医院药学部/北京市老年病医疗研究中心/国家老年疾病临床医学研究中心
- 作者简介：
- 基金信息：
- DOI：10.14009/j.issn.1672-2124.2020.05.028
  CLC： R969
- Published：2020，
扫描看全文
[1]张青霞,褚燕琦,曾艳,沈江华,王欣,王育琴,闫素英.苯巴比妥和苯妥英钠血药浓度监测电子申请单录入错误原因分析与改进[J].中国医院用药评价与分析,2020,20(05):617-619+624.

ZHANG Qingxia, CHU Yanqi, ZENG Yan, et al. Analysis and Improvement of Input Errors in Electronic Application Form of Blood Concentration Monitoring of Phenobarbital and Phenytoin Sodium. [J]. 20(5):617-619(2020)
[1]张青霞,褚燕琦,曾艳,沈江华,王欣,王育琴,闫素英.苯巴比妥和苯妥英钠血药浓度监测电子申请单录入错误原因分析与改进[J].中国医院用药评价与分析,2020,20(05):617-619+624. DOI： 10.14009/j.issn.1672-2124.2020.05.028.

ZHANG Qingxia, CHU Yanqi, ZENG Yan, et al. Analysis and Improvement of Input Errors in Electronic Application Form of Blood Concentration Monitoring of Phenobarbital and Phenytoin Sodium. [J]. 20(5):617-619(2020) DOI： 10.14009/j.issn.1672-2124.2020.05.028.

摘要

目的:探讨医师开具的苯巴比妥和苯妥英钠血药浓度电子申请单录入错误的原因

并制定针对性的改进措施。方法:利用根本原因分析法

回顾性分析医师开具的苯巴比妥和苯妥英钠血药浓度电子申请单录入错误的根本原因

找出苯巴比妥和苯妥英钠药名看似听似（look-alike and sound-alike

LASA）、电脑位置相邻及医师工作繁忙核对不足两大真因

分别制定针对性的防范措施

即将计算机系统中苯巴比妥、苯妥英钠的位置隔开和针对医师核对不足进行培训

并引入PDCA循环进行逐步改进。结果:经过2轮针对性的PDCA逐步改进

医师开具的苯巴比妥、苯妥英钠血药浓度电子申请单录入错误从每月平均4例逐渐降至每月0例。结论:医师要警惕电脑系统LASA药品位置相邻带来的药品混淆错误隐患

LASA药品名称在计算机屏幕内位置隔开可以显著减少医师血药浓度申请单录入错误。

Abstract

OBJECTIVE: To probe into the reasons of input errors in electronic application form of blood concentration monitoring of phenobarbital and phenytoin sodium

so as to formulate specific improvement measures.METHODS: Root cause analysis was adopted to retrospectively analyze the root cause of input errors in electronic application form in blood concentration monitoring of phenobarbital and phenytoin sodium

two main reasons were found out: the Chinese names of phenobarbital and phenytoin sodium were look alike and sound-alike（ LASA） and in adjacent locations in computer

the clinician was too busy to check the electronic application form. Specific preventive measures were formulated respectively: separate the locations of phenobarbital and phenytoin sodium in computer system and training the clinicians for medical order check

the PDCA cycle was also introduced to improve step by step. RESULTS: After two rounds of specific PDCA improvement

the input errors in electronic application form of blood concentration monitoring of phenobarbital and phenytoin sodium had decreased from averagely 4 cases each month to 0. CONCLUSIONS: Clinicians should be aware of possible mix-ups errors of LASA drugs and adjacent locations in computer systems

to separate the locations of LASA drugs can significantly decrease the input errors in electronic application form of blood concentration monitoring.

关键词

PDCA循环血药浓度苯巴比妥苯妥英钠监测错误LASA

Keywords

PDCA cycleBlood concentrationPhenobarbitalPhenytoin sodiumMonitoring errorLASA

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Pharmacodynamic Analysis of Levetiracetam in the Treatment of Epilepsy in Children

Retrospective Analysis of Blood Concentration Monitoring of Cyclosporine A in the Treatment of Psoriasis

Research on the Value of Blood Concentration and Gene Detection of Methotrexate in the Treatment of Low-Risk Gestational Trophoblastic Neoplasia

Effect of Configuration Concentration and Patient’s Basic Renal Function on the Safety of Vancomycin

Determination of the Concentration of Micafungin in Human Plasma by HPLC and its Application in Critical Patients

Related Author

LI Xingang

LU Wei

WEI Minji

WU Ye

WANG Li

WANG Yinghui

LI Xinyu

GONG Chunyan

Related Institution

Peking University School of Pharmaceutical Sciences

Dept.of Pediatric, Peking University First Hospital

Dept.of Pediatric, Beijing Friendship Hospital, Capital Medical University

Dept.of Pharmaceutical Research,Institute of Dermatology,Chinese Academy of Medical Sciences and Peking Union Medical College

Dept.of Pharmacy,Hospital of Dermatology,Chinese Academy of Medical Sciences and Peking Union Medical College

⁰